Login / Signup

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Novel Biomarker for Prognostic Assessment and Risk Stratification of Acute Pulmonary Embolism.

Haixu YuWei RongJie YangJie LuKe MaZhuohui LiuHui YuanLei XuYulin LiZhi-Cheng JingJie Du
Published in: Journal of clinical medicine (2022)
Reduced plasma TRAIL levels predict short-term adverse events in normotensive patients with acute PE. The combination of the 2019 ESC algorithm and TRAIL aids risk stratification in normotensive patients with acute PE.
Keyphrases